You may be right. Just watch out for the P&D on the news.
A CE mark may be big news for stock holders on HC, but the commercial reality is that it is but one very small step to making a profit. Along with an IDE, quickly followed by an HDE, then they may get the interest of SRX or another player. The US really IS the place to be, due to the reimbursement situation. imo.
The health systems in the EU are all strapped for cash and have very low annual limits for these type of procedures, unless it is a 'miracle cure' type of event. And the market in AUS and NZ is tiny.
Best.
You may be right. Just watch out for the P&D on the news. A CE...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.010(0.86%) |
Mkt cap ! $21.74M | |||
| Open | High | Low | Value | Volume |
| $1.17 | $1.17 | $1.14 | $80.47K | 69.48K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2150 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 7380 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| OSL (ASX) Chart |